26.500
−10,77%
2026-10-13
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +42.7% | -116.7% | 2 / 3 | +897.7% | +352.86 pp | +745.32 pp | -17.9% | 2.52 | — | 153 | +897,7% | −110 | +11,8% | — | -708.86 | — |
| Pts | 8 | 0 | 8 | 12 | 12 | 12 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 26.500 (close price on 2026-10-13)EPS (TTM): −1.760,3
Financial charts
1.Revenue & growth
VND bn153Q2/26
1.Revenue & growth
VND bn153Q2/26
2.Profit & growth
VND bn-110Q2/26
3.Profit mix (Penman)
VND bn-490Q2/26
4.Margins & cost structure
%-37.2%Q2/26
5.Returns & cash cycle
% · days-2.3%Q2/26
6.Earnings quality & cash
VND bn-500Q2/26
7.Asset structure
VND bn15.089Q2/26
8.Funding & debt health
VND bn · times15.089Q2/26
9.Revenue backlog
VND bn1.038Q2/26
10.Valuation
times · %-15,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-309Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
53.9%
Source: vnstockData through Q2/26